Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 833.00 | 817.25 | 1.0193 | 1.0284 |
| BT-20 | Lapatinib | 1 | uM | 9 | 625.00 | 320.09 | 841.00 | 817.25 | 1.0291 | 1.0428 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 832.00 | 817.25 | 1.0180 | 1.0266 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1373.00 | 1780.00 | 0.7714 | 0.6569 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1696.00 | 1780.00 | 0.9528 | 0.9311 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1270.00 | 1780.00 | 0.7135 | 0.5658 |
| BT-20 | Linsitinib | 10 | uM | 9 | 1250.00 | 684.27 | 1279.00 | 1780.00 | 0.7185 | 0.5738 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1738.00 | 1780.00 | 0.9764 | 0.9657 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 946.00 | 1780.00 | 0.5315 | 0.2647 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1495.00 | 1780.00 | 0.8399 | 0.7623 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 684.27 | 1697.00 | 1780.00 | 0.9534 | 0.9319 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2021.00 | 1780.00 | 1.1354 | 1.1929 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 1250.00 | 684.27 | 2202.00 | 1780.00 | 1.2371 | 1.3336 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2137.00 | 1780.00 | 1.2006 | 1.2834 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 2065.00 | 1780.00 | 1.1601 | 1.2274 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 684.27 | 2025.00 | 1780.00 | 1.1376 | 1.1960 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1917.00 | 1780.00 | 1.0770 | 1.1105 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 684.27 | 1866.00 | 1780.00 | 1.0483 | 1.0696 |
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1104.00 | 1780.00 | 0.6202 | 0.4146 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 684.27 | 1752.00 | 1780.00 | 0.9843 | 0.9771 |
| BT-20 | Lapatinib | 10 | uM | 9 | 1250.00 | 684.27 | 723.00 | 1780.00 | 0.4062 | 0.0407 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1802.00 | 1780.00 | 1.0124 | 1.0179 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1940.00 | 1780.00 | 1.0899 | 1.1288 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 684.27 | 1738.00 | 1780.00 | 0.9764 | 0.9657 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1561.00 | 1780.00 | 0.8770 | 0.8184 |